Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a multicentric randomized phase III trial comparing adjuvant chemotherapy with gemcitabine versus 5-fluorouracil, leucovorin, irinotecan and oxaliplatin (mFolfirinox) in patients with resected pancreatic adenocarcinoma.
Epistemonikos ID: 60324fc244eeb53672eaf6219238a05337b1cd24
First added on: May 10, 2024